Hutton Scott

President & CEO

Hutton Scott has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 23, 2026.

On the most recent filing, Hutton Scott is listed as President & CEO at BIODESIX INC. Inside the rolling window, Hutton Scott reported no open-market purchases and 4 open-market sales totaling $64K in BDSX. The largest disclosed transaction in the window is a sale of 3,559 BDSX shares on Feb 10, 2026, worth $36K.

Companies traded

Other insiders at BDSX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$64K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BDSXSale$19KFeb 23SEC ↗
BDSXSale$36KFeb 11SEC ↗
BDSXSale$8KJan 20SEC ↗
BDSXSale$1KNov 13SEC ↗
Showing 1–4 of 4
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hutton Scott made?

Hutton Scott has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.

Which companies does Hutton Scott trade?

Hutton Scott has filed SEC Form 4 disclosures for 1 company, including BDSX.

When was Hutton Scott's most recent SEC Form 4 filing?

Hutton Scott's most recent SEC Form 4 filing on Tracefour is dated Feb 23, 2026.

What is Hutton Scott's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hutton Scott is listed as President & CEO.

What is Hutton Scott's total buy and sell value in the current window?

Inside the rolling retention window, Hutton Scott bought $0 and sold $64K based on SEC Form 4 filings.

What was Hutton Scott's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,559 BDSX shares on 2026-02-10, worth $36K, per SEC Form 4 filings.